IGHE and infection: Four publications (3 RCT; n = 350) reported data on infections from adverse event data, in infants with IgE and non IgE mediated CMPA who received AAF-Syn or AAF alone, over periods from 8 weeks to 12 months (Table 3) [31,32,33,39].